Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allos Therapeutics, Inc.
Allos Therapeutics Reports 2008 Second Quarter Results
August 23rd, 2008
Allos Therapeutics, Inc. (NASDAQ: ALTH) reported results for the second quarter of 2008. For the three months ended June 30, 2008, the Company reported a net loss of $11.8 million, or ($0.16) per share. This compares to a net loss of $10.4 million, or ($0.16) per share, for the second quarter of 2007. For the six months ended June 30, 2008, the Company reported a net loss of $23.8 million, or ($0.34) per share, compared to a net loss of $18.8 million, or ($0.29) per share for the same period last year. For the six months ended June 30, 2008, net cash used in operating activities was $19.5 million. Cash, cash equivalents and investments in marketable securities as of June 30, 2008 were...
Source: Law & Health Weekly (2008-08-23)
|
